Market expert Neeraj Dewan sees short-term trading bounces in IT due to overselling, but cautions on long-term AI disruption. Solar stocks might offer medium-term opportunities after sharp falls. Metals are buy-on-dips, while pharma’s GLP-1 segment faces competitive uncertainty despite structural positivity. Defence remains a long-term investment, with rerating pauses expected.Read More
National Stock Exchange of India Ltd. has invited banks to pitch for roles in its long-delayed IPO, signalling fresh momentum for one of India’s biggest potential listings. The exchange, guided by Rothschild & Co., is moving to appoint advisers as it revives plans stalled by regulatory hurdles.Read More
Biocon CEO Siddharth Mittal outlines the company’s strategy in the competitive GLP-1 market. Focusing on liraglutide’s launch in the US and Europe, he highlights opportunities in emerging markets. While semaglutide is a longer-term play, Biocon is actively filing for approvals, anticipating launches in 2027.Read More
Australian stocks hit a fresh record high for the second day, driven by strong performances from miners, healthcare, and tech sectors amid a robust earnings season and rising commodity prices. Miners, in particular, saw significant gains, with BHP and Rio Tinto reaching new peaks. However, Qantas Airways experienced a notable slump due to its international division’s profit decline.Read More
Shares of XTGlobal Infotech hit the 20% upper circuit at Rs 33.18 on the BSE after the company secured an AI Enablement for Engineering Services contract from a US-based state transportation agency. The six-month engagement is valued at about $796,900. Managing Director Ramarao Atchuta Mullapudi said the win strengthens its transportation vertical and US public sector presence.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
